Further studies should investigate CR-1's effect on ERK 1/2 activation, TGF-β/smad-2 signaling blockade, and TGF-β/activin B signaling blockade in ESCC cells. This evidence concerns the gene TGFB1 and esophageal squamous cell carcinoma.